共 223 条
[1]
Ringe JD(2010)Osteoporosis in men Medicographia 32 71-8
[2]
Hiligsmann M(2011)Trends in hip fracture incidence and in the prescription of anti-osteoporosis medications in Belgium (2000–2007) Arthritis Care Res (Hoboken) 64 744-50
[3]
Bruyere O(2000)Long-term risk of osteoporotic fracture in Malmo Osteoporos Int 11 669-74
[4]
Roberfroid R(2010)Meta-analysis: excess mortality after hip fracture among older women and men Ann Intern Med 152 380-90
[5]
Kanis JA(2004)The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459-68
[6]
Johnell O(2008)Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial Arthritis Rheum 58 1687-95
[7]
Oden A(2005)Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816-22
[8]
Haentjens P(2008)Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia J Bone Miner Res 23 433-8
[9]
Magaziner J(2012)Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis Osteoporosis Int 23 1115-22
[10]
Colon-Emeric CS(2006)An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials Osteoporos Int 17 1781-93